ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -90.7% | 66,770 | -86.7% | 0.00% | -85.7% |
| Q2 2023 | $696 | +2220.0% | 500,769 | +2478.2% | 0.01% | – |
| Q1 2023 | $30 | -75.6% | 19,423 | -2.2% | 0.00% | -100.0% |
| Q4 2022 | $123 | -100.0% | 19,856 | -57.0% | 0.00% | -33.3% |
| Q3 2022 | $309,000 | +45.8% | 46,195 | +38.0% | 0.00% | +50.0% |
| Q2 2022 | $212,000 | -82.0% | 33,466 | -85.8% | 0.00% | -71.4% |
| Q4 2021 | $1,177,000 | -47.1% | 235,475 | +27.5% | 0.01% | -50.0% |
| Q3 2021 | $2,225,000 | +448.0% | 184,684 | +2606.0% | 0.01% | -17.6% |
| Q4 2019 | $406,000 | – | 6,825 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |